Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. Our platform has all of the same elements as a human immune system, meaning you can test drugs and vaccines as if you were testing them in actual patients from the start. The biggest reason why 92% of new drugs fail is that they were tested in mice - but with our human platform, pharma companies will know which drugs will successfully treat patients, speeding up the process and reducing the cost. The company is founded by a former Stanford R&D director with a PhD in immunology and a former biotech R&D lead with an MSc in bioengineering, who both have years of experience building technologies for drug discovery. Our headquarters is in Los Angeles, CA.